Granting indemnity is like giving a concessional request of legal protection from any claims linked to the use of their Covid-19 vaccines in India. India has so far not given an indemnity to any COVID vaccine manufacturer against the costs of compensation for any severe side effects so far.
In a big move to clear the way for foreign vaccines like Pfizer and Moderna, the drug regulator has done away with the requirement of India-specific trials.
India s Drug Regulator DCGI Exempts Local Bridging Trials For Foreign Vaccines Approved By WHO And Select Overseas Regulators swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.
India News: In a letter, DCGI Chief VG Somani letter said that this will be applicable for vaccines that have already been approved for restricted use by the US